Why Chronic Heart Failure Management Programs are So Important: Results of the Which Intervention is Most Cost-Effective and Consumer Friendly in Reducing Hospital Care? (WHICH?) Trial - 28/07/12
Doi : 10.1016/j.hlc.2012.05.024
P. Newton 1, ⁎, P. Davidson 1, P. Macdonald 2, S. Stewart 3
1 Centre for Cardiovascular & Chronic Care, University of Technology Sydney, Australia
2 St Vincent’s Hospital & Victor Chang Cardiac Research Institute, Sydney, Australia
3 Preventative Health, Baker IDI Heart and Diabetes Institute, Melbourne, Australia
Corresponding author.
Il testo completo di questo articolo è disponibile in PDF.
© 2012
Pubblicato da Elsevier Masson SAS.
Vol 21 - N° S1
P. S7 - 2012 Ritorno al numero
Articolo precedente
- Process Change Improves Time to Treatment and is Associated with Better Outcomes for ST-Segment Elevation Myocardial Infarction (STEMI) Patients Undergoing Primary Percutaneous Coronary Intervention
- L. Martin, M. Murphy, A. Scanlon, C. Naismith, L. Moore, R. Gehrig-Mills, J. Basile, S. Judkins, D. Clark, O. Farouque
- Abnormal microRNA Expression in Cardiac Hypertrophy and the Regulation of the Endog Gene
- S. Quarrell, F. Marques, V. Jayaswal, C. Curl, S. Nankervis, J. Yang, L. Delbridge, S. Harrap, F. Charchar
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?